Invasion and migration is the hallmark of malignant
tumors as well as the major cause for
breast cancer death. The polypyrimidine tract binding,
PTB, protein serves as an important model for understanding how
RNA binding proteins affect proliferation and invasion and how changes in the expression of these
proteins can control complex programs of
tumorigenesis. We have investigated some roles of
polypyrimidine tract binding protein 1 (PTBP1) in human
breast cancer. We found that PTBP1 was upregulated in
breast cancer tissues compared with normal tissues and the same result was confirmed in
breast cancer cell lines. Knockdown of PTBP1 substantially inhibited
tumor cell growth, migration, and invasion. These results suggest that PTBP1 is associated with breast
tumorigenesis and appears to be required for
tumor cell growth and maintenance of
metastasis. We further analyzed the relationship between PTBP1 and clinicopathological parameters and found that PTBP1 was correlated with her-2 expression,
lymph node metastasis, and pathological stage. This will be a novel target for her-2(+ )
breast cancer. PTBP1 exerts these effects, in part, by regulating the
phosphatase and
tensin homolog-phosphatidylinositol-4,5-bisphosphate 3-
kinase/protein kinase B (PTEN-PI3K/Akt) pathway and autophagy, and consequently alters cell growth and contributes to the invasion and
metastasis.